SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Vessel Closure

Vessel Closure

Hemostasis Management Solutions

Abbott is committed to providing hemostasis management solutions to help patients and hospitals thrive. Time management, patient and staff flow, hospital costs, and throughput can all impact overall hospital efficiency.

Our hemostasis management portfolio aims to drive hospital efficiency through:

  • Early ambulation5,7,8,9
  • Reducing patient length of stay5,7,8,9
  • Lowering access site-related complications5,8,9
  • Improving patient outcomes6,7

 

  • Optimizing nursing time5,8,9
  • Driving overall hospital efficiency5,8,9
  • Improving patient flow5,8,9

Vascular Closure Systems
 

Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System12

  • The Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System is the next generation design evolution of the proven and trusted Perclose ProGlide™ SMC System.
  • Similar to the Perclose ProGlide™ device, each Perclose™ ProStyle™ device delivers the same secure, non-masking percutaneous suture to the access site that promotes primary intention healing1 and has no reaccess restrictions.12
  • The updated Perclose™ ProStyle™ SMCR System has been designed with features such as high-tensile strength needles for more reliability in complex and challenging anatomies, additional visual cues for a more intuitive deployment experience, and the addition of our popular Perclose™ Snared Knot Pusher which offers a more tactile and tapered knot advancement.11
Perclose ProStyle

Perclose ProGlide™ Suture-Mediated Closure (SMC) System13

  • Perclose ProGlide™ SMC System delivers a secure, non-masking percutaneous suture to the access site that promotes primary healing1 and has no reaccess restrictions.13
  • This system has the broadest arterial and venous indication*; it can be utilized for 5-21F2 (Max. 26F OD4) arterial sheaths and 5-24F3 (Max. 29F OD4) venous sheaths.
Perclose ProGlide

StarClose SE™ Vascular Closure System (VCS)14

  • StarClose SE™ Vascular Closure System can be utilized after arterial access procedures using 5-6F introducer sheaths and provides safe10, easy and extravascular percutaneous closure for diagnostic or interventional procedures.
StarClose SE™ Vascular Closure System (VCS)

Prostar XL™ Percutaneous Vascular Surgical System (PVSS)15

  • Prostar XL™ Percutaneous Vascular Surgical (PVS) System is designed for use in conjunction with 8.5-24F sheaths, and uses two braided sutures to provide a secure closure for femoral arterial access sites.
Prostar XL™ Percutaneous Vascular Surgical System (PVSS)

Compression Assist Devices
 

FemoStop™ Femoral Compression Systems16

The FemoStop™ Compression Assist Device uses hands-free compression of the femoral artery or vein to offer precise hemostasis management and patient comfort.

  • The adjustable belt fits securely so that small patient movements may not cause the device to slip and patients can rest comfortably
  • Hands-free compression
    • Allows multiple patients to be monitored at one time, increasing staff efficiency
    • Minimizes staff exposure to blood and reduces neck, arm and wrist fatigue
Femostop Gold
Manuals & Technical Resources

Manuals & Technical Resources

Order Cardiovascular Products

Cardiovascular Products

Customer Service

Customer Service

References

*As compared to Angio-Seal‡, ExoSeal‡, FemoSeal‡, InClosure‡, MANTA‡, Mynx‡, PerQseal‡, Vascade‡, Velox CD‡, X-Seal‡. Data on file at Abbott.

  1. Primary intention healing occurs where vessel wall edges are brought together, adjacent to each other. This can be achieved with sutures and other methods. Advances in Skin & Wound Care: Healing by Intention. Salcido, Richard. 2017.
  2. For arterial sheath sizes greater than 8F, at least two devices and the pre-close technique are required.
  3. For venous sheath sizes greater than 8F, at least one device and the pre-close technique are required.
  4. Max. OD 26F = 0.340 inches = 8.62 mm; Max. OD 29F = 0.378 inches = 9.59 mm. Data on file at Abbott.
  5. Fabbricatore D et al. (2023) Ambulatory PV isolation workflow using suture-mediated vascular closure devices: a prospective observational cohort study. (PRO-PVI Study). Europace. 25(4):1361-1368
  6. Perclose ProGlide Versus Surgical Closure Outcomes - Real World Evidence. Schneider, Darren B; Krajcer, Zvonimir; et al. LINC 2018
  7. The Use of the Perclose ProGlide Suture Mediated Closure (SMC) Device for Venous Access-Site Closure up to 24F Sheaths. Kar, Saibal; Hermiller, James; et al. CRT 2018.
  8. Feasibility and Safety of Same Day Discharge for Patients Undergoing Atrial Fibrillation (AF) Ablation in a Community Hospital Setting. HRS 2020 Poster.
  9. Verma S. Same-Day Discharge for AF Ablation: What Have We Learned - EP Lab Digest - August 2020.
  10. Burke et al. StarClose Vascular Closure System (VCS) is Safe and Effective in Patients Who Ambulate Early Following Successful Femoral Artery Access Closure - Results from the RISE Clinical Trial. CCI 2012, 80:45-52.
  11. Data on file at Abbott.
  12. Perclose™ ProStyle™ SMCR System - Instructions for Use (IFU). Refer to IFU for additional information.
  13. Perclose ProGlide™ SMC System - Instructions for Use (IFU). Refer to IFU for additional information.
  14. StarClose SE™ VCS System - Instructions for Use (IFU). Refer to IFU for additional information.
  15. Prostar XL™ PVS System - Instructions for Use (IFU). Refer to IFU for additional information.
  16. FemoStop™ II Plus Femoral Compression System - Instructions for Use (IFU). Refer to IFU for additional information.

MAT-2010062 v3.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0